Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment
Autor: | Renxuan Huang, Yichun He, Beiwu Lan, Liankun Sun, Yufei Gao, Chong Wang, Nan Wang, Rui Dong, Peining Zhu |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.medical_treatment Adaptive change Drug resistance Malignancy Targeted therapy 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Glioma Regulated cell death Ferroptosis Humans Medicine Brain Neoplasms business.industry Cell Biology General Medicine medicine.disease 030104 developmental biology Drug Resistance Neoplasm Cancer cell Cancer research business 030217 neurology & neurosurgery |
Zdroj: | Cellular and Molecular Neurobiology. 42:2055-2074 |
ISSN: | 1573-6830 0272-4340 |
DOI: | 10.1007/s10571-021-01092-5 |
Popis: | Ferroptosis is a type of regulated cell death that plays an essential role in various brain diseases, including cranial trauma, neuronal diseases, and brain tumors. It has been reported that cancer cells rely on their robust antioxidant capacity to escape ferroptosis. Therefore, ferroptosis exploitation could be an effective strategy to prevent tumor proliferation and invasion. Glioma is a common malignant craniocerebral tumor exhibiting complicated drug resistance and survival mechanisms, resulting in a high mortality rate and short survival time. Recent studies have determined that metabolic alterations in glioma offer exploitable therapeutic targets. These metabolic alterations allow targeted therapy to achieve some initial efficacy but have failed to inhibit glioma growth, invasion, and drug resistance effectively. It has been proposed that the reason for the high malignancy and drug resistance observed with glioma is that these tumors can effectively evade ferroptosis. Ferroptosis-inducing drugs were found to exert a positive effect by targeting this particular characteristic of glioma cells. Moreover, gliomas develop enhanced drug resistance through anti-ferroptosis mechanisms. In this study, we provided an overview of the mechanisms by which glioma aggressiveness and drug resistance are mediated by the evasion of ferroptosis. This information might provide new targets for glioma therapy as well as new insights and ideas for future research. |
Databáze: | OpenAIRE |
Externí odkaz: |